Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jerry J Flores, Yang Zhang, Damon W Klebe, Tim Lekic, Weiling Fu & John H Zhang. (2014) Small molecule inhibitors in the treatment of cerebral ischemia. Expert Opinion on Pharmacotherapy 15:5, pages 659-680.
Read now
Read now
Dong Kug Choi, Sushruta Koppula, Mijung Choi & Kyoungho Suk. (2010) Recent developments in the inhibitors of neuroinflammation and neurodegeneration: inflammatory oxidative enzymes as a drug target. Expert Opinion on Therapeutic Patents 20:11, pages 1531-1546.
Read now
Read now
Articles from other publishers (24)
Jiheng Hao, Yao Feng, Xin Xu, Long Li, Kun Yang, Gaolei Dai, Weiwei Gao, Meng Zhang, Yaming Fan, Tengkun Yin, Jiyue Wang, Bin Yang, Liqun Jiao & Liyong Zhang. (2022) Plasma Lipid Mediators Associate With Clinical Outcome After Successful Endovascular Thrombectomy in Patients With Acute Ischemic Stroke. Frontiers in Immunology 13.
Crossref
Crossref
Hui-Yuan Su, Yi-Cheng Tsai, Hung-Pei Tsai & Chih-Lung Lin. (2022) Zileuton, a 5-Lipoxygenase Inhibitor, Attenuates Haemolysate-Induced BV-2 Cell Activation by Suppressing the MyD88/NF-κB Pathway. International Journal of Molecular Sciences 23:9, pages 4910.
Crossref
Crossref
Te-Yu Hung, Chin-Wei Huang & Sheng-Nan Wu. (2020) High ability of zileuton ((±)-1-(1-benzo[b]thien-2-ylethyl)-1-hydroxyurea) to stimulate IK(Ca) but suppress IK(DR) and IK(M) independently of 5-lipoxygenase inhibition. European Journal of Pharmacology 887, pages 173482.
Crossref
Crossref
Akari Nakamura, Kento Otani & Takashi Shichita. (2020) Lipid mediators and sterile inflammation in ischemic stroke. International Immunology 32:11, pages 719-725.
Crossref
Crossref
Hua-bin Zhang, Xian-kun Tu, Shi-wei Song, Ri-sheng Liang & Song-sheng Shi. (2020) Baicalin Reduces Early Brain Injury after Subarachnoid Hemorrhage in Rats. Chinese Journal of Integrative Medicine 26:7, pages 510-518.
Crossref
Crossref
Cai-Hong Liu, Yuan-Zhi Tan, Dan-Dan Li, Su-Su Tang, Xiao-An Wen, Yan Long, Hong-Bin Sun, Hao Hong & Mei Hu. (2020) Zileuton ameliorates depressive-like behaviors, hippocampal neuroinflammation, apoptosis and synapse dysfunction in mice exposed to chronic mild stress. International Immunopharmacology 78, pages 105947.
Crossref
Crossref
Su Jing Chan, Mary P. E. Ng, Hui Zhao, Geelyn J. L. Ng, Chuan De Foo, Peter T.-H. Wong & Raymond C. S. Seet. (2019) Early and Sustained Increases in Leukotriene B4 Levels Are Associated with Poor Clinical Outcome in Ischemic Stroke Patients. Neurotherapeutics 17:1, pages 282-293.
Crossref
Crossref
Syed Obaidur Rahman, Rakesh Kumar Singh, Salman Hussain, Mohd. Akhtar & Abul Kalam Najmi. (2019) A novel therapeutic potential of cysteinyl leukotrienes and their receptors modulation in the neurological complications associated with Alzheimer's disease. European Journal of Pharmacology 842, pages 208-220.
Crossref
Crossref
Dan-Dan Li, Hang Xie, Yi-Feng Du, Yan Long, Miranda N. Reed, Mei Hu, Vishnu Suppiramaniam, Hao Hong & Su-Su Tang. (2018) Antidepressant-like effect of zileuton is accompanied by hippocampal neuroinflammation reduction and CREB/BDNF upregulation in lipopolysaccharide-challenged mice. Journal of Affective Disorders 227, pages 672-680.
Crossref
Crossref
Zhang Tao, Hua Yue, Luo Hao, Chen Hongmei, Shao Meng, Fu Xiuqiong, John Man-Tak Chu, Huang Guiqiong, Liu Bin & Zhou Yingchun. (2017) Differential gene expression profile of Buyanghuanwu decoction in rats with ventricular remodeling post-myocardial infarction. Journal of Traditional Chinese Medicine 37:3, pages 341-354.
Crossref
Crossref
Paolo Gelosa, Francesca Colazzo, Elena Tremoli, Luigi Sironi & Laura Castiglioni. (2017) Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases. Mediators of Inflammation 2017, pages 1-15.
Crossref
Crossref
Arijit Ghosh, Fang Chen, Abhimanyu Thakur & Hao Hong. (2016) Cysteinyl Leukotrienes and Their Receptors: Emerging Therapeutic Targets in Central Nervous System Disorders. CNS Neuroscience & Therapeutics 22:12, pages 943-951.
Crossref
Crossref
Xian-kun Tu, Hua-bin Zhang, Song-sheng Shi, Ri-sheng Liang, Chun-hua Wang, Chun-mei Chen & Wei-zhong Yang. (2016) 5-LOX Inhibitor Zileuton Reduces Inflammatory Reaction and Ischemic Brain Damage Through the Activation of PI3K/Akt Signaling Pathway. Neurochemical Research 41:10, pages 2779-2787.
Crossref
Crossref
FENG-TAO JI, JIAN-JUN LIANG, LI-PING MIAO, QIANG WU & MING-HUI CAO. (2015) Propofol post-conditioning protects the blood brain barrier by decreasing matrix metalloproteinase-9 and aquaporin-4 expression and improves the neurobehavioral outcome in a rat model of focal cerebral ischemia-reperfusion injury. Molecular Medicine Reports 12:2, pages 2049-2055.
Crossref
Crossref
Juan Gaztanaga, Michael Farkouh, James H.F. Rudd, Tilmann M. Brotz, David Rosenbaum, Venkatesh Mani, Todd C. Kerwin, Rebecca Taub, Jean-Claude Tardif, Ahmed Tawakol & Zahi A. Fayad. (2015) A phase 2 randomized, double-blind, placebo-controlled study of the effect of VIA-2291, a 5-lipoxygenase inhibitor, on vascular inflammation in patients after an acute coronary syndrome. Atherosclerosis 240:1, pages 53-60.
Crossref
Crossref
Xiao-Yan Zhang, Lu Chen, Yi Yang, Dong-Min Xu, Si-Ran Zhang, Chen-Tan Li, Wei Zheng, Shu-Ying Yu, Er-Qing Wei & Li-Hui Zhang. (2014) Regulation of rotenone-induced microglial activation by 5-lipoxygenase and cysteinyl leukotriene receptor 1. Brain Research 1572, pages 59-71.
Crossref
Crossref
Song-sheng Shi, Wei-zhong Yang, Xian-kun Tu, Chun-hua Wang, Chen-mei Chen & Yan Chen. (2013) 5-Lipoxygenase Inhibitor Zileuton Inhibits Neuronal Apoptosis Following Focal Cerebral Ischemia. Inflammation 36:6, pages 1209-1217.
Crossref
Crossref
Phillip Pian, Edward Labovitz, Keith Hoffman, Claudia F. Clavijo, Rachael Rzasa Lynn, Jeffrey L. Galinkin, Alexander A. Vinks, Punam Malik & Uwe Christians. (2013) Quantification of the 5-lipoxygenase inhibitor zileuton in human plasma using high performance liquid chromatography–tandem mass spectrometry. Journal of Chromatography B 937, pages 79-83.
Crossref
Crossref
Mary Chatterjee, Subhadeep Das, Kaushik Roy & Malay Chatterjee. (2011) Overexpression of 5‐lipoxygenase and its relation with cell proliferation and angiogenesis in 7,12‐dimethylbenz(α)anthracene‐induced rat mammary carcinogenesis. Molecular Carcinogenesis 52:5, pages 359-369.
Crossref
Crossref
Marcio de Araujo Furtado, Franco Rossetti, Soma Chanda & Debra Yourick. (2012) Exposure to nerve agents: From status epilepticus to neuroinflammation, brain damage, neurogenesis and epilepsy. NeuroToxicology 33:6, pages 1476-1490.
Crossref
Crossref
J. Marc Simard, Zhihua Geng, Frank L. Silver, Kevin N. Sheth, W. Taylor Kimberly, Barney J. Stern, Mario Colucci & Volodymyr Gerzanich. (2012) Does inhibiting Sur1 complement rt-PA in cerebral ischemia?. Annals of the New York Academy of Sciences 1268:1, pages 95-107.
Crossref
Crossref
Anna Morancho, Anna Rosell, Lidia García-Bonilla & Joan Montaner. (2010) Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment?. Annals of the New York Academy of Sciences 1207:1, pages 123-133.
Crossref
Crossref
Xian-kun Tu, Wei-zhong Yang, Chun-hua Wang, Song-sheng Shi, Yong-liang Zhang, Chun-mei Chen, Yi-kun Yang, Chang-dan Jin & Shuai Wen. (2010) Zileuton Reduces Inflammatory Reaction and Brain Damage Following Permanent Cerebral Ischemia in Rats. Inflammation 33:5, pages 344-352.
Crossref
Crossref
Xian-kun Tu, Wei-zhong Yang, Song-sheng Shi, Chun-hua Wang, Guo-liang Zhang, Tian-rui Ni, Chun-mei Chen, Rui Wang, Jian-wen Jia & Qi-min Song. (2010) Spatio-Temporal Distribution of Inflammatory Reaction and Expression of TLR2/4 Signaling Pathway in Rat Brain Following Permanent Focal Cerebral Ischemia. Neurochemical Research 35:8, pages 1147-1155.
Crossref
Crossref